ITM2B Truncation Promotes Migrasome Formation to Accelerate Renal Cell Carcinoma Growth
Advanced Science · 2026
DOI: 10.1002/advs.202511683 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Qi-Tao Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiamen University, Xiamen, Fujian, 361102, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Membrane Proteins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Postdoctoral Fellowship Program of CPSF.
Abstract (Originalsprache)
Integral membrane protein 2B (ITM2B), a transmembrane protein, frequently undergoes cleavage. The physiological functions of ITM2B are primarily studied in the context of neurological disorders, but their roles in cancers are largely overlooked. Here, it is demonstrated that in renal cell carcinoma (RCC) cells, N‐terminal truncation of ITM2B facilitates migrasome swelling through the recruitment of TSPAN4 and promotes migrasome formation. Moreover, ITM2B truncation acts as a carrier, sorting active caspase‐7 into migrasomes for migracytosis. The active caspase‐7‐enriched migrasomes are then taken up by macrophages, leading to caspase‐7‐induced IL‐6 secretion from macrophages, which eventually aggravates RCC growth through a feedback mechanism. Physiologically, hyperuricemia enhances ITM2B cleavage to aggravate RCC growth. Clinically, RCC tissues tend to produce ITM2B truncations compared with corresponding para‐carcinoma tissues. Moreover, compared with the urine from normal volunteers, that from RCC patients contains higher levels of ITM2B truncation‐enriched migrasomes. This study not only highlights novel functions of ITM2B truncation in migrasome formation and active caspase‐7 migracytosis but also elucidates the role of hyperuricemia in RCC progression via regulation of the ITM2B truncation–migrasome axis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiamen University, Xiamen, Fujian, 361102, China.
- Department of Gastrointestinal Surgery, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian, 361004, China.
ORCID-Profile: Qi-Tao Chen, Qiao-Ling Huang, Ming-Zhi Han, Xue-Hui Hong, Wen-Bin Hong, Hang-Zi Chen, Qiao Wu
Förderung
- National Natural Science Foundation of China
- Postdoctoral Fellowship Program of CPSF
Zitieren
APA
Chen, Q. T., Huang, Q. L., Han, M. Z., Hong, X. H., Feng, D. Y., Yao, L. M., Hong, W. B., Chen, Y., Huang, Y. Y., Chen, H. Z., & Wu, Q. (2026). ITM2B Truncation Promotes Migrasome Formation to Accelerate Renal Cell Carcinoma Growth. Advanced Science. https://doi.org/10.1002/advs.202511683
Vancouver
Chen QT, Huang QL, Han MZ, Hong XH, Feng DY, Yao LM, et al. ITM2B Truncation Promotes Migrasome Formation to Accelerate Renal Cell Carcinoma Growth. Advanced Science. 2026. doi:10.1002/advs.202511683
BibTeX
@article{Chen2026,
author = {Chen, Qi-Tao and Huang, Qiao-Ling and Han, Ming-Zhi and Hong, Xue-Hui and Feng, De-Yi and Yao, Lu-Ming and Hong, Wen-Bin and Chen, Yue and Huang, Ya-Ying and Chen, Hang-Zi and Wu, Qiao},
title = {ITM2B Truncation Promotes Migrasome Formation to Accelerate Renal Cell Carcinoma Growth},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202511683}
}
EUVIMED